HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

3-Aminobenzamide reduces brain infarction and neutrophil infiltration after transient focal cerebral ischemia in mice.

Abstract
Poly(ADP-ribose) polymerase (PARP) was shown to be detrimental in cerebral ischemia but the mechanisms whereby PARP is deleterious have yet to be determined. They may include a role in neutrophil infiltration known to aggravate ischemic damage. In this context, we investigated the effect of 3-aminobenzamide (3-AB), a PARP inhibitor, on brain damage and neutrophil infiltration after transient focal cerebral ischemia in mice. Ischemia was induced in male Swiss mice, anaesthetized with chloral hydrate (400 mg/kg, i.p.), by a 15-min-occlusion of the left middle cerebral artery using an intraluminal suture. Treatments with 3-AB were first administered intraperitoneally 15 min before reperfusion and endpoints measured at 24 h. Among the range of dosages studied (20-320 mg/kg), 40 mg/kg gave the maximal neuroprotection with a 30% decrease in the infarct volume and tended to improve the neurological score evaluated by a grip test. The same dosage was, however, devoid of effect when injection was delayed 2 or 6 h after reperfusion. Myeloperoxidase (MPO) activity used as an index of neutrophil infiltration showed that infiltration peaked 48 h after reperfusion in our model. At this time point, 3-AB (40 mg/kg given 15 min before reperfusion) markedly reduced the neutrophil infiltration, as evidenced by a 72%-decrease in MPO activity, and was still neuroprotective. Our results confirm that 3-AB reduces brain damage. Moreover, for the first time, a quantitative study shows that 3-AB decreases neutrophil infiltration elicited by cerebral ischemia.
AuthorsJérôme Y Couturier, Li Ding-Zhou, Nicole Croci, Michel Plotkine, Isabelle Margaill
JournalExperimental neurology (Exp Neurol) Vol. 184 Issue 2 Pg. 973-80 (Dec 2003) ISSN: 0014-4886 [Print] United States
PMID14769390 (Publication Type: Journal Article)
Chemical References
  • Benzamides
  • Enzyme Inhibitors
  • Neuroprotective Agents
  • Poly(ADP-ribose) Polymerase Inhibitors
  • 3-aminobenzamide
  • Peroxidase
Topics
  • Animals
  • Benzamides (pharmacology)
  • Brain Infarction (drug therapy, etiology, pathology)
  • Dose-Response Relationship, Drug
  • Enzyme Inhibitors (pharmacology)
  • Ischemic Attack, Transient (complications)
  • Male
  • Mice
  • Neuroprotective Agents (pharmacology)
  • Neutrophil Infiltration (drug effects)
  • Peroxidase (metabolism)
  • Poly(ADP-ribose) Polymerase Inhibitors
  • Reperfusion
  • Time Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: